Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

COVID-19 Resources »      Vaccine Update »      Visitor Policy »

Von Hippel-Lindau Syndrome

What Is Von Hippel-Lindau Syndrome?

Von Hippel-Lindau syndrome (VHL) is a rare genetic disorder that causes an increased risk of certain kinds of tumors. Two eye doctors—von Hippel in Germany and Lindau in Sweden—were the first to publish descriptions of tumors in patients' eyes and brains, hallmarks of von Hippel-Lindau syndrome. In the 1960s the disease was named VHL, von Hippel-Lindau, to recognize their contributions in characterizing the disease.

INTERESTED IN AN ONLINE SECOND OPINION?

The Stanford Medicine Online Second Opinion program offers you easy access to our world-class doctors. It’s all done remotely and you don’t have to visit our hospital or one of our clinics for this service. You don’t even need to leave home!

Visit our online second opinion page to learn more.

Clinics for Von Hippel-Lindau Syndrome